{"schema_version":"secwatch.filing_event.v1","accession":"0000715787-21-000041","form_type":"8-K","ticker":"TILE","cik":"0000715787","company_name":"INTERFACE INC","filed_at":"2021-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.339794+00:00","generated_at":"2026-06-28T12:24:19.910162+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Interface Q3 net sales up 12% to $313M; adjusted EPS $0.29 vs $0.28 YoY","bullets":["GAAP EPS $0.19, up from $0.10; net income $11.0M vs $5.9M in Q3 2020.","Orders increased 24% YoY; Americas orders up 34%, EAAA up 12%.","Q4 net sales guidance $320M-$330M; adjusted gross margin 35.5%-36.5%.","Debt reduced by $30M in Q3; cash on hand $92.8M, total debt $525M.","European carpet tile backing now fully converted to bio-based CQuest™Bio."],"urls":{"canonical":"https://secwatch.observer/filing/0000715787-21-000041","json":"https://secwatch.observer/filing/0000715787-21-000041.json","markdown":"https://secwatch.observer/filing/0000715787-21-000041.md","text":"https://secwatch.observer/filing/0000715787-21-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/715787/000071578721000041/0000715787-21-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/715787/000071578721000041/tile-20211105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T12:24:19.910162+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}